Ann: Trading Halt, page-76

The last time we had a CR at 2c..........this was said

“Transformational capital raising”

Patrys chief executive officer and managing director James Campbell said: “This is a transformational capital raising for Patrys that positions the company to effectively leverage the wide range of therapeutic opportunities provided by its unique deoxymab platform.

“The funds are expected to allow the company to complete all the pre-clinical studies and manufacturing required to initiate the anticipated first-in-man studies of PAT-DX1.

“Patrys can now also focus on realising the breadth of the platform, by accelerating the development of the PAT-DX3 (full sized antibody) program, and advancing the PAT-DX1-NP program.

“Importantly, funds will also be applied to a new program on antibody drug conjugates (ADCs) based on deoxymab assets.

Now I am expecting something very similar to be said...............hopefully better. More likely that PAT_DX3 needs money to get results